跳至主要内容
临床试验/NCT05198661
NCT05198661招募中不适用

Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection

Hospices Civils de Lyon77 个研究点 分布在 1 个国家目标入组 3,500 人开始时间: 2022年8月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
3,500
试验地点
77
主要终点
Blood Samples

研究概览

简要总结

Numerous neurological disorders affecting the central and peripheral nervous system can be attributed to the immune system through multiple effector mechanisms. However, current treatments could be drastically improved by faster and more accurate diagnosis. The sample collection will benefit to patients with rare neuroimmune syndromes such as Autoimmune Encephalitis (AE) and Paraneoplastic Neurological Syndromes (PNS) leading to a better and early diagnosis, as well as treatment improvement.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient with consent
  • Patient with well-characterized antibodies in serum or cerebrospinal fluid or not
  • Patient with neurological disorder compatible with PNS or auto-immune encephalitis

排除标准

  • Refusal of consent
  • Patient under guardianship

研究组 & 干预措施

Paraneoplastic neurological syndrome patients and autoimmune encephalitis patient

Other

patients with diagnosis of paraneoplastic neurological syndrome or autoimmune encephalitis

干预措施: Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma. (Biological)

结局指标

主要结局

Blood Samples

时间窗: 10 years

Assessment of biocollection of blood samples

Cerebrospinal fluid biocollection

时间窗: 10 years

Assessment of biocollection of Cerebrospinal fluid

次要结局

  • Scientific collaboration(10 years)
  • Scientific(10 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (77)

Loading locations...

相似试验